Assignee
OXIGENE INC
US·17 granted patents·3 pending applications·168 citations·filing 1994–2014
Top patents by PatentIndex Score
20 records- 0193US6538038B1Compositions and methods for use in targeting vascular destructionOXIGENE INC·Filed 2000·Granted Mar 25, 2003·63 cites·12 claims
- 0283US7384925B2Functionalized stilbene derivatives as improved vascular targeting agentsOXIGENE INC·Filed 2005·Granted Jun 10, 2008·6 cites·8 claims
- 0377US8877967B2Compositions and methods for inhibition of cathepsinsOXIGENE INC·Filed 2013·Granted Nov 4, 2014·4 cites·20 claims
- 0474US7358236B1Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agentsOXIGENE INC·Filed 2003·Granted Apr 15, 2008·5 cites·13 claims
- 0573US9458103B2Compositions and methods for inhibition of cathepsinsOXIGENE INC·Filed 2014·Granted Oct 4, 2016·2 cites·8 claims
- 0673US6773702B2Use of combretastatin A4 and its prodrugs as an immune enhancing therapyOXIGENE INC·Filed 2001·Granted Aug 10, 2004·5 cites·13 claims
- 0773US6020351ACarotenoid-nicotinamide-zinc compositions and methods of treatment using sameOXIGENE INC·Filed 1996·Granted Feb 1, 2000·32 cites·13 claims
- 0870US6956054B2Compositions and methods for use in targeting vascular destructionOXIGENE INC·Filed 2002·Granted Oct 18, 2005·4 cites·16 claims
- 0963US2009192098A1Method for treating hematopoietic neoplasmsOXIGENE INC·Filed 2008·Application pending·0 cites
- 1062US6339073B1Uses of nicotinamide adenine dinucleotide and its derivatives for treatment of malignant and infectious diseasesOXIGENE INC·Filed 1998·Granted Jan 15, 2002·18 cites·6 claims
- 1161USRE45720EFunctionalized stilbene derivatives as improved vascular targeting agentsOXIGENE INC·Filed 2014·Granted Oct 6, 2015·0 cites·12 claims
- 1259USRE45907EFunctionalized stilbene derivatives as improved vascular targeting agentsOXIGENE INC·Filed 2014·Granted Mar 1, 2016·0 cites·8 claims
- 1359US6743937B2Efficient method of synthesizing combretastatin A-4 prodrugsOXIGENE INC·Filed 2001·Granted Jun 1, 2004·4 cites·32 claims
- 1455US2011110940A1Methods for Enhancing the Efficacy of Vascular Disrupting AgentsOXIGENE INC·Filed 2009·Application pending·0 cites
- 1554US6028111ACompositions and use of benzamides and nicotinamides as anti-inflammatory agentsOXIGENE INC·Filed 1997·Granted Feb 22, 2000·11 cites·10 claims
- 1650US6100299AN-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of useOXIGENE INC·Filed 1998·Granted Aug 8, 2000·8 cites·9 claims
- 1742US2009137687A1Compositions and Methods With Enhanced Therapeutic ActivityOXIGENE INC·Filed 2008·Application pending·0 cites
- 1838US5561129AMethods of administering phenothiazines and/or acid addition salts thereofOXIGENE INC·Filed 1995·Granted Oct 1, 1996·2 cites·8 claims
- 1935US5561161AMethods of administering and pharmaceutical formulations containing n-substituted benzamides and/or acid addition salts thereofOXIGENE INC·Filed 1994·Granted Oct 1, 1996·3 cites·27 claims
- 2030US6713517B1Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such useOXIGENE INC·Filed 1997·Granted Mar 30, 2004·1 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when OXIGENE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →